Tag: Zynerba Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Zynerba Pharmaceuticals

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Cut to Sell at ValuEngine

Added to Collection on: 2019-02-28 08:00:00

Tags for this article:

Industries
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zynerba Pharmaceuticals (ZYNE) Rating Lowered to Sell at ValuEngine

Added to Collection on: 2019-03-12 11:33:45

Tags for this article:

Money
Finance
NASDAQ
Stock market
Stock
Financial markets
Corporate finance
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zynerba Pharmaceuticals (ZYNE) Upgraded to Buy by ValuEngine

Added to Collection on: 2019-04-30 19:37:30

Tags for this article:

Money
Finance
Economy
Stock
Short
Financial regulation
Pharmaceutical industry in China
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zynerba Pharmaceuticals (ZYNE) Upgraded by ValuEngine to “Buy”

Added to Collection on: 2019-05-15 05:11:15

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
Specialty drugs
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Announces Earnings Results, Beats Estimates By ...

Added to Collection on: 2019-11-14 07:03:37

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zygel, CBD Gel, to Enter Pivotal Trial in Patients With Severe Symptoms

Added to Collection on: 2020-12-18 18:56:15

Tags for this article:

Health
Drugs
Organ systems
Orphan drugs
Analgesics
Anticonvulsants
Cannabidiol
Cannabinoids
Resorcinols
Fragile X syndrome
Food and Drug Administration
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Price Target Cut to $9.00

Added to Collection on: 2020-12-21 12:22:30

Tags for this article:

Finance
Money
Life Sciences
Dividend
Shareholders
Price?earnings ratio
Pharmaceutical industry in China
Financial analyst
Zynerba Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo